188 related articles for article (PubMed ID: 26778368)
1. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical profile of ductal adenocarcinoma of the prostate.
Seipel AH; Samaratunga H; Delahunt B; Wiklund F; Wiklund P; Lindberg J; Grönberg H; Egevad L
Virchows Arch; 2014 Nov; 465(5):559-65. PubMed ID: 25059847
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
4. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
5. Patterns of metastases of prostatic ductal adenocarcinoma.
Ranasinghe WKB; Brooks NA; Elsheshtawi MA; Davis JW; Bathala TK; Tang C; Troncoso P; Aparicio A; Tu SM; Pisters LL; Chapin BF
Cancer; 2020 Aug; 126(16):3667-3673. PubMed ID: 32453443
[TBL] [Abstract][Full Text] [Related]
6. Ductal adenocarcinoma of the prostate: Clinical and biological profiles.
Vinceneux A; Bruyère F; Haillot O; Charles T; de la Taille A; Salomon L; Allory Y; Ouzaid I; Choudat L; Rouprêt M; Comperat E; Houede N; Beauval JB; Vourc'h P; Fromont G
Prostate; 2017 Sep; 77(12):1242-1250. PubMed ID: 28699202
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
8. Genetic profile of ductal adenocarcinoma of the prostate.
Seipel AH; Whitington T; Delahunt B; Samaratunga H; Mayrhofer M; Wiklund P; Grönberg H; Lindberg J; Egevad L
Hum Pathol; 2017 Nov; 69():1-7. PubMed ID: 28457729
[TBL] [Abstract][Full Text] [Related]
9. Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features.
Seipel AH; Delahunt B; Samaratunga H; Egevad L
Pathology; 2016 Aug; 48(5):398-405. PubMed ID: 27321992
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
11. Prostatic ductal adenocarcinoma: a mini review.
Epstein JI
Med Princ Pract; 2010; 19(1):82-5. PubMed ID: 19996627
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity of HOXB13 as a Diagnostic Immunohistochemical Marker of Prostatic Origin in Prostate Cancer Metastases: Comparison to PSA, Prostein, Androgen Receptor, ERG, NKX3.1, PSAP, and PSMA.
Kristiansen I; Stephan C; Jung K; Dietel M; Rieger A; Tolkach Y; Kristiansen G
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555048
[TBL] [Abstract][Full Text] [Related]
13. PTEN loss and ERG protein expression are infrequent in prostatic ductal adenocarcinomas and concurrent acinar carcinomas.
Morais CL; Herawi M; Toubaji A; Albadine R; Hicks J; Netto GJ; De Marzo AM; Epstein JI; Lotan TL
Prostate; 2015 Oct; 75(14):1610-9. PubMed ID: 26178158
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiles of ductal versus acinar adenocarcinoma of the prostate.
Sanati S; Watson MA; Salavaggione AL; Humphrey PA
Mod Pathol; 2009 Oct; 22(10):1273-9. PubMed ID: 19633648
[TBL] [Abstract][Full Text] [Related]
15. Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers.
Tarján M; Chen HH; Tot T; Wu W; Lenngren A; Dean PB; Tabár L
Scand J Urol Nephrol; 2012 Aug; 46(4):258-66. PubMed ID: 22519924
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical verification of ductal differentiation in prostate cancer.
Tarján M; Lenngren A; Hellberg D; Tot T
APMIS; 2012 Jun; 120(6):510-8. PubMed ID: 22583364
[TBL] [Abstract][Full Text] [Related]
17. Histopathological features of ductal adenocarcinoma of the prostate in 1,051 radical prostatectomy specimens.
Seipel AH; Wiklund F; Wiklund NP; Egevad L
Virchows Arch; 2013 Apr; 462(4):429-36. PubMed ID: 23443941
[TBL] [Abstract][Full Text] [Related]
18. Atypical ductal adenocarcinoma of the prostate with endometrioid immunohistological features.
Lucan M; Vasiliu V; Iacob G; Lucan V
Chirurgia (Bucur); 2009; 104(3):355-8. PubMed ID: 19601472
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic criteria for ductal adenocarcinoma of the prostate: interobserver variability among 20 expert uropathologists.
Seipel AH; Delahunt B; Samaratunga H; Amin M; Barton J; Berney DM; Billis A; Cheng L; Comperat E; Evans A; Fine SW; Grignon D; Humphrey PA; Magi-Galluzzi C; Montironi R; Sesterhenn I; Srigley JR; Trpkov K; van der Kwast T; Varma M; Zhou M; Ahmad A; Moss S; Egevad L
Histopathology; 2014 Aug; 65(2):216-27. PubMed ID: 24467262
[TBL] [Abstract][Full Text] [Related]
20. Variants and unusual patterns of prostate cancer: clinicopathologic and differential diagnostic considerations.
Fine SW
Adv Anat Pathol; 2012 Jul; 19(4):204-16. PubMed ID: 22692283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
